VEGFA and age-related macular degeneration: To cure AMD and DR, the most commonly used FDA-approved drugs like anti-VEGF agents in computational prediction shows higher robustness index to functional subnetwork, especially angiogenesis subnetwork, which is consistent with remarkable clinical benefits for anti-VEGF therapy.